Piretanide

This classification denotes a loop diuretic with the molecular formula C17H18N2O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DQ6KK6GV93, chemically known as benzoic acid, 3-(aminosulfonyl)-4-phenoxy-5-(pyrrolidinyl)- but generally known as piretanide, which bears US NIH Compound Identifier 4849. European Medicines Agency schedules Piretanide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09906MIG. The term PIRETANIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, No. 10 1975, List 15). World Health Organization schedules piretanide in its Anatomical Therapeutic Chemical (ATC) Classification. PIRETANIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule piretanide under HS 29350090 and SITC 51580. As of Q4 2014, PIRETANIDE remains the US FDA Preferred Term for this commodity. Piretanide bears US NLM identifiers UMLS ID C0071132 and NCI Concept Code C66419. SMILES: S(=O)(=O)(N)c1c(Oc2ccccc2)c(N2CCCC2)cc(c1)C(=O)O.